LAMP3 and colorectal cancer: In colorectal cancer, high LAMP3 expression was significantly associated with poor overall survival in univariate analysis (HR, 2.919, 95% CI, 1.666-5.114; P<0.001), along with previously reported prognostic markers, including differentiation (HR, 4.047, 95% CI, 2.227-7.353; P<0.001), tumor stage (HR, 2.126, 95% CI, 1.500-3.012; P=0.003), and preoperative CEA level (HR, 2.510, 95% CI, 1.354-4.651; P=0.003).